Dr. Vicky Makker, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Endometrial Cancer
Studies Mullerian Tumor
8 reported clinical trials
11 drugs studied
Area of expertise
1Endometrial Cancer
Stage IV
Stage I
Stage III
2Mullerian Tumor
MSI-H positive
dMMR positive
HER2 positive
Affiliated Hospitals
Clinical Trials Vicky Makker, MD is currently running
CLN-619 + Pembrolizumab
for Cancer
This trial is testing a new drug called CLN-619 alone and with pembrolizumab in patients with advanced solid tumors. These patients may not have other treatment options. Pembrolizumab helps the immune system fight cancer, and they are seeing if CLN-619 can help too.
Recruiting1 award Phase 110 criteria
Pembrolizumab + Lenvatinib
for Uterine Cancer
The purpose of this study to find out whether the combination of lenvatinib and pembrolizumab is an effective treatment for advanced uterine carcinosarcoma. The researchers will also do tests to find out whether biomarkers in the blood can predict the cancer's response to the study treatment. A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition
Recruiting1 award Phase 210 criteria
More about Vicky Makker, MD
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Vicky Makker, MD has experience with
- Pembrolizumab
- Ketogenic Diet
- Nivolumab
- BMS-986205
- ZW25
- Lenvatinib
Breakdown of trials Vicky Makker, MD has run
Endometrial Cancer
Mullerian Tumor
Fallopian Tube Carcinosarcoma
Endometrial Carcinosarcoma
Childhood Obesity
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vicky Makker, MD specialize in?
Vicky Makker, MD focuses on Endometrial Cancer and Mullerian Tumor. In particular, much of their work with Endometrial Cancer has involved Stage IV patients, or patients who are Stage I.
Is Vicky Makker, MD currently recruiting for clinical trials?
Yes, Vicky Makker, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Vicky Makker, MD has studied deeply?
Yes, Vicky Makker, MD has studied treatments such as Pembrolizumab, Ketogenic Diet, Nivolumab.
What is the best way to schedule an appointment with Vicky Makker, MD?
Apply for one of the trials that Vicky Makker, MD is conducting.
What is the office address of Vicky Makker, MD?
The office of Vicky Makker, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.